About the Journal : The International Journal of Mycobacteriology

Secondary Logo

Journal Logo

About the Journal


International Journal of Mycobacteriology, a publication of Asian African Society of Mycobacteriology​, is a peer-reviewed online journal with Quarterly  print on demand compilation of issues published.​ The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.

About the society

​​​​​Who we are :

The "Asian-African Society of Mycobacteriology​" (AASM) is a non-profit, scientific organization with a mission to foster unilateral, bilateral, multilateral networks of scientific, research and training collaborations among experts from AASM countries.

The AASM is committed to :

  • Establish a network of laboratories with the objective of enhancing quality control and quality assurance of mycobacteriology within the inter- and intra-regions in AASM countries.
  • Promote the advancement of diagnosis, treatment and prevention of Mycobacterial diseases.
  • Review and participate in the development of new-diagnostic tests and kits for the rapid detection of mycobacterium.
  • Collaborate and participate in the introduction of new drug(s) and design protocols for the treatment of mycobacterial diseases.
  • Invest and collaborate with laboratories whose activities are directed towards research and development of new vaccines for tuberculosis and other mycobacterial diseases.
  • Facilitate exchange of ideas and information through scientific meetings and publications.
  • Promote inter- and intra-regional cooperation aimed at the prevention of mycobacterial diseases within AASM countries.
  • Promote M.D, PhD and specialist training programmes within the AASM countries and in collaboration with other established universities throughout the world.
  • Secure funding for researcher(s) in the development of new
  • Diagnostic kits and procedures.
  • Facilitate and promote research on mycobacterial diseases for outstanding researchers.
  • Advise, collaborate and participate with governmental and non-governmental agencies in matters of common interest.
  • Establish and maintain close linkages with international agencies involved in the prevention of mycobacterial diseases worldwide ( e.g., WHO, CDC,ASM,IUATLD,. etc).
  • Raise funds and seek donations to support activities in the prevention of mycobacterial diseases.

Abstracting and Indexing Information​

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN centre, ProQuest, TDNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ, EMBASE/ Excerpta Medica, Emerging Sources Citation Index, MEDLINE/Index Medicus, Scimago Journal Ranking, SCOPUS, Web of Science

Impact Factor® as reported in the 2022 Journal Citation Reports® (Clarivate Analytics, 2023): 1.2

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. 

The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any

OAI-compliant institutional / subject-based repository.​

Manuscripts received from Editorial Board members will be screened by the Editor in Chief and sent to external peer reviewers. The editorial

board members who are authors will be excluded from publication decisions.​


Digital Archiving

Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.

Ahead of Print policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.


While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

Scope of the journal

The Journal will cover Basic and clinical studies related to health, ethical and social issues in field of Clinical and Epidemiological studies of Mycobacterial infection, Microbiology of mycobacterium, Epidemiology of mycobacterium, Molecular biology of mycobacterium, Clinical features of mycobacterium. Articles with clinical interest and implications will be given preference.

Medknow Publications

Medknow, part of Wolters Kluwer Health, is one of the largest open access publishers worldwide with more than 450+ medical journals in its portfolio. Students, researchers, clinicians and other healthcare professionals worldwide access Medknow journals to help them fuel new discoveries and improve patient care.

Founded in 1997, Medknow is a well-respected medical publisher that fully supports many of the popular open access models through its peer-review management system. Medknow’s open access policy has resulted in more than a half a million article downloads monthly for all of its journals.

Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Lippincott Williams & WilkinsOvid®UpToDate®Medi-Span®Facts & Comparisons®Pharmacy OneSource®Lexicomp® and ProVation® MedicalWolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with annual revenues (2019) of €3.4 billion ($4.7 billion), approximately 19,000 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.

Medknow Specialties
Online and Print Scholarly Publishing, Peer-Review System, Specialized in Medical Research, Largest Open Access Publisher